Abstract
Accurate diagnosis of frontotemporal dementia (FTD) with right anterior temporal lobe (RATL) predominance remains challenging due to lack of clinical characterization, and standardized terminology. The recent research of the International Working Group (IWG) identified common symptoms but also unveiled broad terminologies lacking precision and operationalization, with risk of misdiagnoses, inappropriate referrals and poor clinical management. Based on the published evidence (91267 articles screened) and expert opinion (105 FTD specialists across 52 centers), the IWG delineates three primary domains of impairment causing behavioral, memory and language problems: (i) multimodal knowledge of non-verbal information including people, living beings, landmarks, flavors/odors, sounds, bodily sensations, emotions and social cues; (ii) socioemotional behavior encompassing emotion expression, social response and motivation; and (iii) prioritization for focus on specific interests, hedonic valuation and personal preferences. This study establishes a consensus on clinical profile, phenotypic nomenclature, and future directions to enhance diagnostic precision and therapeutic interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project is supported by AACSF-22-849085 PI: Ulugut. Josephs and Whitwell are supported by R01-AG37491 R01-DC010367 R21-NS94684. Van den Stock is supported by KU Leuven (IDN/21/010 and C24/18/095) and the Sequoia Fund for research on ageing and mental health. Santillo is supported by the Swedish federal government under the ALF agreement. Bertoux is supported by the Fondation Planiol the Fondation France Alzheimer and Fondation Vaincre Alzheimer. Laforce; Chaire de recherche sur les aphasies primaires progressives Fondation de la Famille Lemaire. Warren is supported by the Alzheimer's Society Alzheimer's Research UK the Royal National Institute for Deaf People the NIHR UCLH Biomedical Research Centre and a Frontotemporal Dementia Research Fellowship in Memory of David Blechner (funded through The National Brain Appeal). Rankin is supported by RF1-AG029577. Rowe is funded by the Medical Research Council (MC_UU_00030/14; MR/T033371/1); the NIHR Cambridge Biomedical Research Centre (NIHR203312) and Wellcome Trust (220258). Vandenberghe receives support from the Mady Browaeys Fonds voor Onderzoek naar Frontotemporale Degeneratie.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB od UCSF waived ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14076
